Page last updated: 2024-10-31

mianserin and Lung Diseases, Obstructive

mianserin has been researched along with Lung Diseases, Obstructive in 1 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Lung Diseases, Obstructive: Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grove, A1
Lipworth, BJ1
Ingram, CG1
Clark, RA1
Dhillon, DP1

Trials

1 trial available for mianserin and Lung Diseases, Obstructive

ArticleYear
A comparison of the effects of prednisolone and mianserin on ventilatory, exercise and psychometric parameters in patients with chronic obstructive pulmonary disease.
    European journal of clinical pharmacology, 1995, Volume: 48, Issue:1

    Topics: Aged; Anxiety; Double-Blind Method; Exercise; Female; Heart Rate; Humans; Lung Diseases, Obstructive

1995